Clinical trial
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common…
NCT00352963 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00352963 |
|---|---|
| Title | Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). |
| Official title | Study to Assess Immunogenicity and Reactogenicity of Three Doses of GSK Bio's Combined Hib-MenC Vaccine Co-admind With GSK Bio's DTPa-HBV-IPV Vaccine and of Two Doses of Baxters Meningococcal C Conjugate Vaccine Co-admind With GSK Bio's DTPa-HBV-IPV/Hib Vaccine |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Poliomyelitis, Tetanus, Acellular Pertussis, Hepatitis B, Diphtheria |
| Intervention type | Biological |
| Interventions | Study vaccines: IH+Hib-MenC/NVC, Control: IH+Meningitec |
| Enrollment | 480 |
| Start date | Sep 30, 2003 |
| Completion | Jul 16, 2004 |
| First posted | Jul 17, 2006 |
| Last update posted | Jan 6, 2020 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: